Remyelination promoting therapies in multiple sclerosis animal models: a systematic review and meta-analysis

An unmet but urgent medical need is the development of myelin repair promoting therapies for Multiple Sclerosis (MS). Many such therapies have been pre-clinically tested using different models of toxic demyelination such as cuprizone, ethidium bromide, or lysolecithin and some of the therapies alrea...

Descripción completa

Detalles Bibliográficos
Autores principales: Hooijmans, Carlijn R., Hlavica, Martin, Schuler, Florian A. F., Good, Nicolas, Good, Andrin, Baumgartner, Lisa, Galeno, Gianluca, Schneider, Marc P., Jung, Tarzis, de Vries, Rob, Ineichen, Benjamin V.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6351564/
https://www.ncbi.nlm.nih.gov/pubmed/30696832
http://dx.doi.org/10.1038/s41598-018-35734-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6351564/
https://www.ncbi.nlm.nih.gov/pubmed/30696832
http://dx.doi.org/10.1038/s41598-018-35734-4

Ejemplares similares